BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P23
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -0.27% |
| Q3 2025 | 2.13% |
| Q2 2025 | 4.33% |
| Q1 2025 | 2.26% |
| Q4 2024 | 2.01% |
| Q3 2024 | -3.06% |
| Q2 2024 | 2.83% |
| Q1 2024 | 0.45% |
| Q4 2023 | 1.23% |
| Q3 2023 | 2.97% |
| Q2 2023 | 2.01% |
| Q1 2023 | 0.92% |
| Q4 2022 | 1.77% |
| Q3 2022 | 1.92% |
| Q2 2022 | 1.37% |
| Q1 2022 | 0.96% |
| Q4 2021 | 0.46% |
| Q3 2021 | 1.34% |
| Q2 2021 | 1.61% |
| Q1 2021 | -0.73% |
| Q4 2020 | -5.04% |
| Q3 2020 | 16.14% |
| Q2 2020 | 12.27% |
| Q1 2020 | 0.70% |
| Q4 2019 | 2.89% |
| Q3 2019 | 3.75% |
| Q2 2019 | -0.95% |
| Q1 2019 | 0.19% |
| Q4 2018 | -5.71% |
| Q3 2018 | 1.53% |
| Q2 2018 | 0.61% |
| Q1 2018 | -0.79% |
| Q4 2017 | 1.14% |
| Q3 2017 | 13.95% |
| Q2 2017 | 2.07% |
| Q1 2017 | -2.11% |
| Q4 2016 | 4.72% |
| Q3 2016 | 24.45% |
| Q2 2016 | -15.81% |
| Q1 2016 | -1.67% |